New combo therapy aims to outperform chemo for rare urinary tract cancer

NCT ID NCT06120374

First seen Jan 05, 2026 · Last updated May 14, 2026 · Updated 23 times

Summary

This study looks at whether combining radiation and immunotherapy works better than standard chemotherapy for people with high-risk upper urinary tract cancer. The goal is to prevent the cancer from coming back after surgery. About 178 adults with certain high-risk features will be followed to compare outcomes like how long they live without the cancer returning.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for UROTHELIAL CARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Departmeng of Urology, Peking University First Hospital

    RECRUITING

    Beijing, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Department of Medical Oncology, Peking University First Hospital

    RECRUITING

    Beijing, China

    Contact Email: •••••@•••••

    Contact Email: •••••@•••••

  • Department of Radiotherapy Oncology, Peking University First Hospital

    RECRUITING

    Beijing, China

    Contact Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.